Search results
Richard W Troughton
Job title: Professor of Medicine
Author
Andrew Vanezis
Job title: Consultant Cardiologist
Author
Sotiris Antoniou
Research Area(s) / Expertise:
Job title: Consultant Pharmacist & Lead Cardiovascular Pharmacist
Author
Karim Al-Azizi
Job title: Interventional Cardiologist and Structural Heart Disease Specialist
Author
Added:
7 months ago
Source:
Radcliffe Cardiology
New data from the SEQUOIA-HCM trial suggests that the cardiac myosin inhibitor aficamten provides significant clinical benefits for patients with obstructive hypertrophic cardiomyopathy (oHCM) and mild symptoms, with an efficacy and safety profile comparable to that seen in patients with more advanced symptoms.¹Aficamten is a novel, selective cardiac myosin inhibitor that works by reducing the…
View more
Pam Taub
Job title: Professor of Medicine
Author
Michael Piorkowski
Job title: Specialist in Internal Medicine, Cardiology and Angiology
Author
Ewa Jankowska
Research Area(s) / Expertise:
Author
Expertise
Heart FailureHeart Failure ComorbiditiesCardiomyopathiesPrevention & Chronic ConditionsCardiomyopathies and Cardiac AmyloidosisChronic Kidney DiseaseCardiovascular Kidney MetabolicObesityHeart Failure Diagnosis and ImagingGuidelines & StatementsMetabolic dysfunction-associated fatty liver disease (MAFLD)Heart Failure DevicesDiabetesHypertension
Jose Osorio
Research Area(s) / Expertise:
Job title: Medical Director
Author
Dr Won-Keun Kim
Job title: Interventional Cardiologist and Deputy Director of Cardiology & Angiology
Author